EP 1596883 A1 20051123 - INTERFERON DRUG THERAPY FOR THE TREATMENT OF VIRAL DISEASES AND LIVER FIBROSIS
Title (en)
INTERFERON DRUG THERAPY FOR THE TREATMENT OF VIRAL DISEASES AND LIVER FIBROSIS
Title (de)
INTERFERON-THERAPIE ZUR BEHANDLUNG VON VIRUSERKRANKUNGEN UND LEBERFIBROSE
Title (fr)
THERAPIE DE MEDICAMENT INTERFERON POUR LE TRAITEMENT DE MALADIES VIRALES ET HEPATIQUES
Publication
Application
Priority
- US 0341369 W 20031223
- US 0306687 W 20030228
- US 0332539 W 20031014
Abstract (en)
[origin: WO2004078207A1] The present invention provides methods of treating alphavirus infection; methods of treating hepatitis C virus (HCV) infection; methods of treating West Nile virus infection; methods of treating Dengue virus infection; methods of treating yellow fever virus infection; methods of reducing liver fibrosis; methods of increasing liver function in an individual suffering from liver fibrosis; methods of reducing the incidence of complications associated with HCV and cirrhosis of the liver; and methods of reducing viral load, or reducing the time to viral clearance, or reducing morbidity or mortality in the clinical outcomes, in patients suffering from viral infection. The methods generally involve administering a therapeutically effective amount of a Type I or Type III interferon receptor agonist and IFN-gamma for the treatment of viral infection or liver fibrosis.
IPC 1-7
IPC 8 full level
A61K 38/21 (2006.01); A61K 39/29 (2006.01); A61P 31/14 (2006.01)
CPC (source: EP)
A61K 38/212 (2013.01); A61K 38/217 (2013.01); A61P 31/14 (2017.12)
Citation (search report)
See references of WO 2004078207A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004078207 A1 20040916; AU 2003299962 A1 20040928; EP 1596883 A1 20051123
DOCDB simple family (application)
US 0341369 W 20031223; AU 2003299962 A 20031223; EP 03800228 A 20031223